Author:
Gibiansky Leonid,Giraudon Mylène,Rayner Craig R.,Brennan Barbara J.,Subramoney Vishak,Robson Richard,Kamal Mohamed A.
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. FDA Oseltamivir Package Insert http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM183850.pdf . Accessed 26 November 2014
2. Parrott N, Davies B, Hoffmann G, Koerner A, Lave T, Prinssen E, Theogaraj E, Singer T (2011) Development of a physiologically based model for oseltamivir and simulation of pharmacokinetics in neonates and infants. Clin Pharmacokinet 50(9):613–623
3. Kamal MA, Van Wart SA, Rayner CR, Subramoney V, Reynolds DK, Bulik CC, Smith PF, Bhavnani SM, Ambrose PG, Forrest A (2013) Population pharmacokinetics of oseltamivir: pediatrics through geriatrics. Antimicrob Agents Chemother 57(8):3470–3477
4. New Zealand Tamiflu® Data Sheet. www.medsafe.govt.nz/profs/datasheet/t/Tamiflucapsusp.pdf . Accessed 11 January 2013
5. Brennan BJ, Davies B, Cirrincione-Dall G, Morcos PN, Beryozkina A, Chappey C, Aceves Baldó P, Lennon-Chrimes S, Rayner CR (2012) Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteers. Antimicrob Agents Chemother 56(9):4729–4737
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献